These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24159360)

  • 41. Funding and Forums for ELSI Research: Who (or What) is Setting the Agenda?
    Morrissey C; Walker RL
    AJOB Prim Res; 2012 Jan; 3(3):51-60. PubMed ID: 22888470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Dual-Use Education Gap: Awareness and Education of Life Science Researchers on Nonpathogen-Related Dual-Use Research.
    Vinke S; Rais I; Millett P
    Health Secur; 2022; 20(1):35-42. PubMed ID: 35175856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developing a Comprehensive, Adaptive, and International Biosafety and Biosecurity Program for Advanced Biotechnology: The iGEM Experience.
    Millett P; Binz T; Evans SW; Kuiken T; Oye K; Palmer MJ; van der Vlugt C; Yambao K; Yu S
    Appl Biosaf; 2019 Jun; 24(2):64-71. PubMed ID: 36033940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Challenges for the European governance of synthetic biology for human health.
    Douglas CM; Stemerding D
    Life Sci Soc Policy; 2014 Dec; 10():6. PubMed ID: 26085442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resources and strategies to integrate the study of ethical, legal, and social implications of genetics into the undergraduate curriculum.
    Garrett JM; Triman KL
    Adv Genet; 2009; 66():35-59. PubMed ID: 19737637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.
    Bunnik EM; Schermer MH; Janssens AC
    BMC Med Ethics; 2011 Jun; 12():11. PubMed ID: 21672210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three decades of ethical, legal, and social implications research: Looking back to chart a path forward.
    Dolan DD; Lee SS; Cho MK
    Cell Genom; 2022 Jul; 2(7):. PubMed ID: 35935917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BioSin UFMG Club: Engaging a multilevel and multidisciplinary community in synthetic biology.
    Gervásio J; Sampaio Y; Muniz P; Yamada C; Felicori LF
    Biochem Mol Biol Educ; 2022 Mar; 50(2):249-253. PubMed ID: 35150200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evaluation of the Ethical, Legal and Social Implications program of the U.S. Human Genome Project.
    Jin J
    Princet J Bioeth; 2000; 3(1):35-50. PubMed ID: 11936136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BioMaster: An Integrated Database and Analytic Platform to Provide Comprehensive Information About BioBrick Parts.
    Wang B; Yang H; Sun J; Dou C; Huang J; Guo FB
    Front Microbiol; 2021; 12():593979. PubMed ID: 33552037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YouTube resources for synthetic biology education.
    Dy AJ; Aurand ER; Friedman DC
    Synth Biol (Oxf); 2019; 4(1):ysz022. PubMed ID: 32995544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Designing safety policies to meet evolving needs: iGEM as a testbed for proactive and adaptive risk management.
    McNamara J; Lightfoot SB; Drinkwater K; Appleton E; Oye K
    ACS Synth Biol; 2014 Dec; 3(12):983-5. PubMed ID: 25524105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time to Get Serious about Measurement in Synthetic Biology.
    Beal J; Haddock-Angelli T; Farny N; Rettberg R
    Trends Biotechnol; 2018 Sep; 36(9):869-871. PubMed ID: 29880229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mind the Gap: From Tool to Knowledge Base.
    Mayrhofer MT; Schlünder I
    Biopreserv Biobank; 2018 Dec; 16(6):458-462. PubMed ID: 30102551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developing an Ethical and Legal Interoperability Assessment Process for Retrospective Studies.
    Tassé AM; Kirby E; Fortier I
    Biopreserv Biobank; 2016 Jun; 14(3):249-55. PubMed ID: 27115199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SOCIO-ETHICAL ISSUES IN PERSONALIZED MEDICINE: A SYSTEMATIC REVIEW OF ENGLISH LANGUAGE HEALTH TECHNOLOGY ASSESSMENTS OF GENE EXPRESSION PROFILING TESTS FOR BREAST CANCER PROGNOSIS.
    Ali-Khan SE; Black L; Palmour N; Hallett MT; Avard D
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):36-50. PubMed ID: 25991501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Governing biotechnology to provide safety and security and address ethical, legal, and social implications.
    Trump B; Cummings C; Klasa K; Galaitsi S; Linkov I
    Front Genet; 2022; 13():1052371. PubMed ID: 36712887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding Ethical, Legal and Societal Issues (ELSIs) in Human Biobanking and Genomics for Research and Healthcare in Zimbabwe: The Genomics Inheritance Law Ethics and Society (GILES) initiative.
    Matimba A; Chimatira A; Kuguyo O; January J; Mupambireyi Z; Marimbe-Dube B; Chikwasha V; Nyati-Jokomo Z; Muteti S; Mangezvo P; Kangwende A; Chingono A; Chidzonga M; Gandari J; Hakim J; Nathoo K; Samkange C; Mangezi W; Lee S; Gwanzura L; Cho M; Ndebele P
    AAS Open Res; 2019; 2():1. PubMed ID: 32382699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics research on the town hall agenda, courtesy of ELSI. Ethical, Legal, and Social Implications.
    Dove A
    Nat Med; 1998 May; 4(5):541. PubMed ID: 9585212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.